Stockreport

I-Mab Announces Partial Exercise of Over-Allotment Option in Initial Public Offering

I-MAB - American Depositary Shares  (IMAB) 
PDF SHANGHAI, China and ROCKVILLE, MD., Feb. 10, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the [Read more]